A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1
Clinical trial NCT03681184 · COMPLETED
Trial details
- NCT number
- NCT03681184
- Sponsor
- Alnylam Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-27
- Primary completion
- 2019-11-05
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.